Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism
- 15 June 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (23), 2857-2861
- https://doi.org/10.1161/01.cir.0000129307.26791.8e
Abstract
Background— Recent studies suggest that aldosterone may impair endothelium-dependent vascular function through suppression of nitric oxide formation. Assessments of forearm blood flow or arterial compliance suggest a similar effect in humans. The present study was designed to determine whether chronic aldosterone excess in subjects with resistant hypertension impairs endothelium-dependent vascular reactivity as indexed by direct assessment of brachial artery flow-mediated dilation (FMD). Methods and Results— Consecutive subjects (n=80) with resistant hypertension were prospectively evaluated with an early-morning ratio of plasma aldosterone to plasma renin activity and 24-hour urinary aldosterone and sodium. Changes in brachial artery diameter during reactive hyperemia were measured by high-resolution ultrasound. Hyperaldosteronism was diagnosed on the basis of a renin activity 12 μg/24 h, and urinary sodium >200 mEq/24 h. FMD was significantly lower in 36 subjects with hyperaldosteronism (1.8±1.3% versus 3.9±1.9% from baseline; Pr=−0.38, P=0.0006), 24-hour urinary aldosterone (r=−0.49, Pr=−0.43, PPConclusions— These data demonstrate a strong association between aldosterone excess and impaired endothelial function in human subjects as indexed by flow-mediated arterial vasodilation. These results suggest that chronic aldosteronism may have a blood pressure–independent effect on cardiovascular disease progression in subjects with resistant hypertension.Keywords
This publication has 19 references indexed in Scilit:
- Different Effect of Antihypertensive Drugs on Conduit Artery Endothelial FunctionHypertension, 2003
- Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and TreatmentEndocrinology, 2003
- Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial arteryJournal of the American College of Cardiology, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Endothelial Dysfunction: Does It Matter? Is It Reversible?Journal of the American College of Cardiology, 1997
- Impaired endothelial function with essential hypertension assessed by ultrasonographyAmerican Heart Journal, 1996
- Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1995
- Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 βEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Vasodilation to acetylcholine in primary and secondary forms of human hypertension.Hypertension, 1993
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992